SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Encouraging Results from Phase2a Trial of SGX945 in Behcet’s Disease ...

Subcutaneous injections do not require a port like an IV, eliminating the risk for port-related complications such as infections.

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3 clinical study titled ‘MagnetisMM-32’ ...

What if you could inject a drug into a "problem area" – like abdominal fat – that could kill off fat cells and reduce fat ...

The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release.Nivolumab and ...

This study could potentially impact the stock performance of Regeneron Pharmaceuticals and Sanofi, as positive results may enhance investor sentiment and market valuation. The study’s focus on COPD, a ...

The subcutaneous route allows drugs such as insulin and heparin to be absorbed slowly over a period of time. Using the correct injection technique and selecting the correct site will minimise the risk ...

Ocrevus subcutaneous injection was non-inferior to Ocrevus IV infusion as measured by Ocrevus levels in the blood of patients (area under the serum concentration time curve) from day 1 to 12 weeks ...

The opinion is based on positive data from the phase 3 Balance study, which showed a significant reduction of triglycerides ...

CHICAGO — An oral robotic pill may provide an alternative delivery method to subcutaneous injection for teriparatide and other biologics, according to a speaker at ENDO 2023. In findings from a ...